Evidence map›Paper›PMID 31615444›Full record

Trial reportBMC neurology2019

Increased activation of the pregenual anterior cingulate cortex to citalopram challenge in migraine: an fMRI study.

Andrea Edit Edes, Shane McKie, Edina Szabo, Gyongyi Kokonyei, Dorottya Pap, Terezia Zsombok, Mate Magyar, Eva Csepany, Gabor Hullam, Adam Gyorgy Szabo and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Neocortical circuits in pain and pain relief.Nature reviews. Neuroscience · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Andrea Edit EdesSE-NAP2 Genetic Brain Imaging Migraine Research Group, Semmelweis University, Budapest, Hungary.
Shane McKieFaculty of Biological, Medical and Human Sciences Platform Sciences, Enabling Technologies and Infrastructure, Faculty of Biological, Medical and Human Sciences Research and Innovation, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester, UK.
Edina SzaboSE-NAP2 Genetic Brain Imaging Migraine Research Group, Semmelweis University, Budapest, Hungary.
Gyongyi KokonyeiSE-NAP2 Genetic Brain Imaging Migraine Research Group, Semmelweis University, Budapest, Hungary.
Dorottya PapDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Terezia ZsombokDepartment of Neurology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Mate MagyarDepartment of Neurology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Eva CsepanyDepartment of Neurology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Gabor HullamDepartment of Measurement and Information Systems, Budapest University of Technology and Economics, Faculty of Electrical Engineering and Informatics, Budapest, Hungary.
Adam Gyorgy SzaboMR Research Center, Semmelweis University, Budapest, Hungary.
Lajos Rudolf KozakMR Research Center, Semmelweis University, Budapest, Hungary.
Gyorgy BagdyDepartment of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
Gabriella JuhaszSE-NAP2 Genetic Brain Imaging Migraine Research Group, Semmelweis University, Budapest, Hungary. juhasz.gabriella@pharma.semmelweis-univ.hu.ORCID http://orcid.org/0000-0002-5975-4267
Semmelweis University · HUBudapest University of Technology and Economics · HUManchester Academic Health Science Centre · GB

Funding

Hungarian Academy of Sciences, Semmelweis University KTIA_NAP_13-2-2015-0001Hungarian Brain Research Program 2017-1.2.1-NKP-2017-00002New National Excellence Program Of The Ministry Of Human Capacities ÚNKP-17-3-III-ELTE-346New National Excellence Program Of The Ministry Of Human Capacities ÚNKP-17-4-BME-115New National Excellence Program Of The Ministry Of Human Capacities ÚNKP-18-3-III-SE-6
6 · The paper itself

Abstract

backgroundThe anterior cingulate cortex (ACC) is a key structure of the pain processing network. Several structural and functional alterations of this brain area have been found in migraine. In addition, altered serotonergic neurotransmission has been repeatedly implicated in the pathophysiology of migraine, although the exact mechanism is not known. Thus, our aim was to investigate the relationship between acute increase of brain serotonin (5-HT) level and the activation changes of the ACC using pharmacological challenge MRI (phMRI) in migraine patients and healthy controls.

methodsTwenty-seven pain-free healthy controls and six migraine without aura patients participated in the study. All participant attended to two phMRI sessions during which intravenous citalopram, a selective serotonin reuptake inhibitor (SSRI), or placebo (normal saline) was administered. We used region of interest analysis of ACC to compere the citalopram evoked activation changes of this area between patients and healthy participants.

resultsSignificant difference in ACC activation was found between control and patient groups in the right pregenual ACC (pgACC) during and after citalopram infusion compared to placebo. The extracted time-series showed that pgACC activation increased in migraine patients compared to controls, especially in the first 8-10 min of citalopram infusion.

conclusionsOur results demonstrate that a small increase in 5-HT levels can lead to increased phMRI signal in the pregenual part of the ACC that is involved in processing emotional aspects of pain. This increased sensitivity of the pgACC to increased 5-HT in migraine may contribute to recurring headache attacks and increased stress-sensitivity in migraine.

Indexed as

AdultBrain MappingCitalopramDouble-Blind MethodFemaleGyrus CinguliHumansMagnetic Resonance ImagingMaleMiddle AgedMigraine DisordersSelective Serotonin Reuptake InhibitorsSerotoninCitalopramSelective Serotonin Reuptake InhibitorsSerotoninAnterior cingulate cortexCitalopramMigraine without auraPharmacological challenge MRI

Identifiers

PMID31615444
PMCPMC6794781
OpenAlexW2980459254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.